BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

312 related articles for article (PubMed ID: 21987209)

  • 1. Occurrence and fate of pharmaceuticals and personal care products in drinking water in southern China.
    Qiao T; Yu Z; Zhang X; Au DW
    J Environ Monit; 2011 Nov; 13(11):3097-103. PubMed ID: 21987209
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Year-long evaluation on the occurrence and fate of pharmaceuticals, personal care products, and endocrine disrupting chemicals in an urban drinking water treatment plant.
    Padhye LP; Yao H; Kung'u FT; Huang CH
    Water Res; 2014 Mar; 51():266-76. PubMed ID: 24262763
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmaceuticals and personal care products (PPCPs) in surface and treated waters of Louisiana, USA and Ontario, Canada.
    Boyd GR; Reemtsma H; Grimm DA; Mitra S
    Sci Total Environ; 2003 Jul; 311(1-3):135-49. PubMed ID: 12826389
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Occurrence, removal and risk assessment of pharmaceutical and personal care products (PPCPs) in an advanced drinking water treatment plant (ADWTP) around Taihu Lake in China.
    Lin T; Yu S; Chen W
    Chemosphere; 2016 Jun; 152():1-9. PubMed ID: 26943873
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Removal of pharmaceuticals and personal care products by two-stage biofiltration for drinking water treatment.
    Fu J; Lee WN; Coleman C; Nowack K; Carter J; Huang CH
    Sci Total Environ; 2019 May; 664():240-248. PubMed ID: 30743118
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Seasonal and spatial variations of pharmaceuticals and personal care products occurrence and human health risk in drinking water - A case study of China.
    Jiang X; Qu Y; Zhong M; Li W; Huang J; Yang H; Yu G
    Sci Total Environ; 2019 Dec; 694():133711. PubMed ID: 31400687
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Seasonal variation in the occurrence and removal of pharmaceuticals and personal care products in different biological wastewater treatment processes.
    Sui Q; Huang J; Deng S; Chen W; Yu G
    Environ Sci Technol; 2011 Apr; 45(8):3341-8. PubMed ID: 21428396
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fate of selected pharmaceuticals and personal care products after secondary wastewater treatment processes in Taiwan.
    Lin AY; Lin CF; Tsai YT; Lin HH; Chen J; Wang XH; Yu TH
    Water Sci Technol; 2010; 62(10):2450-8. PubMed ID: 21076233
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biological removal of pharmaceuticals and personal care products during laboratory soil aquifer treatment simulation with different primary substrate concentrations.
    Onesios KM; Bouwer EJ
    Water Res; 2012 May; 46(7):2365-75. PubMed ID: 22374299
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Occurrences and removal of pharmaceuticals and personal care products (PPCPs) in drinking water and water/sewage treatment plants: A review.
    Yang Y; Ok YS; Kim KH; Kwon EE; Tsang YF
    Sci Total Environ; 2017 Oct; 596-597():303-320. PubMed ID: 28437649
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Occurrences of pharmaceuticals and personal care products in the drinking water of Taiwan and their removal in conventional water treatment processes.
    Pai CW; Leong D; Chen CY; Wang GS
    Chemosphere; 2020 Oct; 256():127002. PubMed ID: 32445997
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The occurrence of pharmaceuticals, personal care products, endocrine disruptors and illicit drugs in surface water in South Wales, UK.
    Kasprzyk-Hordern B; Dinsdale RM; Guwy AJ
    Water Res; 2008 Jul; 42(13):3498-518. PubMed ID: 18514758
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Occurrence of endocrine disrupting compounds, pharmaceuticals, and personal care products in the Han River (Seoul, South Korea).
    Yoon Y; Ryu J; Oh J; Choi BG; Snyder SA
    Sci Total Environ; 2010 Jan; 408(3):636-43. PubMed ID: 19900699
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fate of pharmaceuticals and personal care products in wastewater treatment plants--conception of a database and first results.
    Miège C; Choubert JM; Ribeiro L; Eusèbe M; Coquery M
    Environ Pollut; 2009 May; 157(5):1721-6. PubMed ID: 19201071
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Occurrence of steroid estrogens, endocrine-disrupting phenols, and acid pharmaceutical residues in urban riverine water of the Pearl River Delta, South China.
    Peng X; Yu Y; Tang C; Tan J; Huang Q; Wang Z
    Sci Total Environ; 2008 Jul; 397(1-3):158-66. PubMed ID: 18407320
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oxidative removal of selected endocrine-disruptors and pharmaceuticals in drinking water treatment systems, and identification of degradation products of triclosan.
    Wu Q; Shi H; Adams CD; Timmons T; Ma Y
    Sci Total Environ; 2012 Nov; 439():18-25. PubMed ID: 23059968
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Occurrence and removal of antibiotics, hormones and several other pharmaceuticals in wastewater treatment plants of the largest industrial city of Korea.
    Behera SK; Kim HW; Oh JE; Park HS
    Sci Total Environ; 2011 Sep; 409(20):4351-60. PubMed ID: 21807398
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Occurrence and health risk assessment of pharmaceutical and personal care products (PPCPs) in tap water of Shanghai.
    Liu M; Yin H; Wu Q
    Ecotoxicol Environ Saf; 2019 Nov; 183():109497. PubMed ID: 31400719
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endocrine disrupting compounds (EDCs) and pharmaceuticals and personal care products (PPCPs) in the aquatic environment: implications for the drinking water industry and global environmental health.
    Rahman MF; Yanful EK; Jasim SY
    J Water Health; 2009 Jun; 7(2):224-43. PubMed ID: 19240349
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fate of endocrine-disruptor, pharmaceutical, and personal care product chemicals during simulated drinking water treatment processes.
    Westerhoff P; Yoon Y; Snyder S; Wert E
    Environ Sci Technol; 2005 Sep; 39(17):6649-63. PubMed ID: 16190224
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.